Regeneron Pharmaceuticals
REGN
#226
Rank
C$116.37 B
Marketcap
$1,059
Share price
2.09%
Change (1 day)
-6.99%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.39

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $53.47. In 2022 the company made an earnings per share (EPS) of $57.99 a decrease over its 2021 EPS that were of $109.41.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.39-13.1%
2022$57.99-47%
2021$109.41133.36%
2020$46.8869.13%
2019$27.72-14.44%
2018$32.40100.71%
2017$16.1431.78%
2016$12.2538.96%
2015$8.8272.55%
2014$5.11-17.55%
2013$6.20-44.98%
2012$11.26-422.54%
2011-$3.4992.13%
2010-$1.8249.41%
2009-$1.22-15.84%
2008-$1.45-36.88%
2007-$2.29-9.6%
2006-$2.534.12%
2005-$2.43-323.68%
2004$1.09-135.51%
2003-$3.06-24.38%
2002-$4.0556.35%
2001-$2.59187.3%
2000-$0.90-16%
1999-$1.07177.78%
1998-$0.39-35.71%
1997-$0.60-68.42%
1996-$1.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.25-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.88-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.42-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.16-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.35-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.55-91.49%๐Ÿ‡ซ๐Ÿ‡ท France